A study will investigate whether it's possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.
An Australian-led study will investigate whether it’s possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.The study will explore the immune response to COVID-19-specific va
Artists Gina Medcalf, Mary Webb, Coco Crampton, Fabian Peake, Charles Hewlings, and Johann Don-Daniel are confirmed for the project along with Bill Jackson, the last artist to exhibit at The Cut before this latest lockdown.
Kasia Posen, local artist and lead on the project said: “It will be exciting to begin collating an accessible record of the exhibitions that have taken place at The Cut over the years, and also have the chance to explore past and present exhibitors current studio practice through our online interviews and studio tours.”
The Bounce Back Fund also provides training for The Cut staff and volunteers and it’s hoped that the camera equipment will allow live events to be streamed to people that feel uncomfortable attending indoor events or those that can’t make a particular evening.
BCG vaccine trial extends across Devon, in partnership with RD&E
A large global trial designed to test the theory that the widely used BCG vaccine might help protect against COVID-19 amongst healthcare staff and care home workers in the UK continues to recruit participants.
The Exeter study site started recruitment in October and is ongoing in the UK and globally. Now, the University of Exeter has partnered with the Royal Devon & Exeter NHS Trust (RD&E) to recruit staff, and has opened new clinics in Teignmouth and North Devon
Researchers in the trial said that as well as finding out if the BCG vaccine reduced COVID-19 disease severity, they would also be testing whether it could boost the effect of specific COVID-19 vaccines by training the body’s immune system.
GP Sam Hilton signs up to BRACE
A large global trial designed to test the theory that the widely used BCG vaccine might help protect against COVID-19 amongst healthcare staff and care home workers in the UK continues to recruit participants.
The Exeter study site started recruitment in October and is ongoing in the UK and globally. Now, the University of Exeter has partnered with the Royal Devon & Exeter NHS Trust (RD&E) to recruit staff, and has opened new clinics in Teignmouth and North Devon
Researchers in the trial said that as well as finding out if the BCG vaccine reduced COVID-19 disease severity, they would also be testing whether it could boost the effect of specific COVID-19 vaccines by training the body’s immune system.